Clinical trial
Randomized Phase III Trial of Adjuvant Chemotherapy With UFT vs. Observation in Curatively Resected Stage II Colon Cancer
NCT00392899 is registered in ClinicalTrials.gov with Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase III Trial of Adjuvant Chemotherapy With UFT vs. Observation in Curatively Resected Stage II Colon Cancer
- Lead sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- September 30, 2016
- Enrollment
- 2,025 (actual)
- Sites
- 272
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer